Improving Coagulation Kinetics: A Mathematical Approach to Incorporating Intermediate Complexes in Thrombin Models

Hemostasis is a vital physiological process that prevents excessive bleeding through a cascade of complex biochemical reactions, resulting in blood clot formation.This process involves a coagulation cascade that converts fibrinogen to fibrin by thrombin.Mathematical models, including the Hockin-Mann, Danforth, and Lakshmanan models, have been instrumental in simulating thrombin generation and understanding the coagulation cascade.However, these models often use simplified reaction schemes and neglect the inclusion of intermediate complexes, which can compromise their accuracy.This study demonstrates that such simplifications distort the time scale and peak values of thrombin generation, leading to misleading results.By modifying all three mathematical models to incorporate classical enzyme kinetics and critical intermediate steps, we show that the modifications change the dynamics of thrombin generation and emphasize the need for a more detailed representation of the biochemical interactions involved.This work underscores the importance of employing comprehensive modeling approaches in coagulation studies to achieve a more accurate representation of thrombotic and hemophilic conditions, ultimately aiding in the development of effective therapeutic strategies. Introduction.Hemostasis is an innate response that stops bleeding when there is an injury to the blood vessel.Hemostasis consists of two components: primary hemostasis, in which platelets accumulate and activate at the site of injury, and secondary hemostasis, in which coagulation reinforces and stabilizes the "platelet plug" by depositing a fibrin mesh network [15].The process of blood clot formation is shown in Figure 1.A crucial part of this process is coagulation, a multi-reaction cascade that ultimately converts fibrinogen to fibrin, forming the structural basis of a stable blood clot.Alterations in hemostatic balance can lead to thrombotic diseases or hemophilia.A better understanding of the coagulation process would permit the kinetics of these diseases to be better understood.Computational modeling can quantify reaction details of complex systems such as coagulation in order to predict experimental conditions and aid laboratory experiments.Mathematical models are particularly valuable because they can simulate intricate interactions between clotting factors, including the end product thrombin, under varying conditions.This approach allows models to investigate scenarios that would be difficult or costly to replicate in a lab setting, such as rare genetic variations or extreme physiological states.Mathematical modeling also provides insight into the nonlinear dynamics of clot formation and dissolution, making it easier to identify key regulatory points in the cascade.These models can be used to test potential interventions, evaluate drug efficacy, and even predict patient-specific responses to therapies, ultimately contributing to more precise and effective treatments for thrombin-related disorders.